All In Biotech

Free tool

FAERS Monitor: Desferal

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 016267 or its brand name (Desferal, Deferoxamine Mesylate). Reports on generic versions are filed under their own applications.

Reports

1,676

Serious

1,487

89% of reports

Hospitalization

631

Death reported

334

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • serum ferritin increased157
  • pyrexia116
  • diarrhoea105
  • haemoglobin decreased101
  • off label use100
  • vomiting90
  • nausea87
  • death85
  • fatigue76
  • drug ineffective75
  • dyspnoea73
  • blood creatinine increased71
  • abdominal pain70
  • pneumonia65
  • malaise64

Reports by year received

View as table
YearReports
200426
200527
200661
200749
200870
200986
201075
2011102
2012128
201363
201498
201595
2016111
2017114
201877
201974
202066
202134
202281
202362
202467
202560
202649

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,483 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
serum ferritin increasedSignal157385.0330.957,978
blood creatinine increasedSignal7113.710.9822
haemoglobin decreasedSignal10112.410.21,047
pyrexiaSignal1164.23.5285
abdominal painSignal703.83.0142
pneumoniaSignal652.52.059
vomitingSignal902.42.074
diarrhoeaSignal1052.01.756
malaise641.81.424
dyspnoea731.61.317
off label use1001.41.213
nausea871.41.19
death851.21.04
fatigue761.21.03
drug ineffective750.70.69

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.